Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 9,178 | 6,599 | 10,056 | 12,192 | 21,543 |
| Gross Profit | 9,178 | 6,599 | 10,056 | 12,192 | 21,543 |
| Operating Expenses | 75,232 | 61,489 | 61,445 | 77,066 | 59,321 |
| Operating Income | -66,054 | -54,890 | -51,389 | -64,874 | -37,778 |
| Other Income | 17,453 | 15,614 | 13,385 | 16,726 | 6,367 |
| Pre-tax Income | -48,601 | -39,276 | -38,004 | -48,148 | -31,411 |
| Income Tax | -1,451 | -10,666 | -7,476 | -8,038 | -1,518 |
| Net Income Continuous | -47,150 | -28,610 | -30,528 | -40,110 | -29,893 |
| Net Income | $-47,150 | $-28,610 | $-30,528 | $-40,110 | $-29,893 |
| EPS Basic Total Ops | -0.16 | -0.10 | -0.11 | -0.14 | -0.10 |
| EPS Basic Continuous Ops | -0.16 | -0.10 | -0.11 | -0.14 | -0.11 |
| EPS Diluted Total Ops | -0.16 | -0.10 | -0.11 | -0.14 | -0.10 |
| EPS Diluted Continuous Ops | -0.16 | -0.10 | -0.11 | -0.14 | -0.10 |
| EBITDA(a) | $-56,945 | $-47,481 | $-44,133 | $-57,754 | $-22,418 |